These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 15482201

  • 1. Fluconazole for the treatment of candidiasis: 15 years experience.
    Cha R, Sobel JD.
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):357-66. PubMed ID: 15482201
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.
    Akush Ginekol (Sofiia); 2016 Jun; 55(4):20-29. PubMed ID: 29370489
    [Abstract] [Full Text] [Related]

  • 4. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning DW, Lortholary O.
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Candida albicans targets that potentially synergize with fluconazole.
    Lu H, Shrivastava M, Whiteway M, Jiang Y.
    Crit Rev Microbiol; 2021 May; 47(3):323-337. PubMed ID: 33587857
    [Abstract] [Full Text] [Related]

  • 10. [A new pharmaceutical concept for the therapy of oropharyngeal and esophageal candidiasis with fluconazole].
    Wildfeuer A, Laufen H, Yeates RA, Zimmermann T.
    Mycoses; 1996 May; 39 Suppl 1():123-6. PubMed ID: 8767284
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic evaluation of fluconazole in critically ill patients.
    Sinnollareddy M, Peake SL, Roberts MS, Playford EG, Lipman J, Roberts JA.
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1431-40. PubMed ID: 21883033
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
    Hata K, Kimura J, Miki H, Toyosawa T, Moriyama M, Katsu K.
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2243-7. PubMed ID: 8891122
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
    Fortun Abete J.
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan.
    Mikamo H, Matsumizu M, Nakazuru Y, Okayama A, Nagashima M.
    J Infect Chemother; 2015 Jul; 21(7):520-6. PubMed ID: 25887336
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp.
    Grant LM, Orenstein R.
    J Investig Med High Impact Case Rep; 2022 Jul; 10():23247096221123144. PubMed ID: 36059275
    [Abstract] [Full Text] [Related]

  • 20. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
    Sherry L, Kean R, McKloud E, O'Donnell LE, Metcalfe R, Jones BL, Ramage G.
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.